Award-winning heating technology specialist Inditherm is predicting a brighter future as demand builds for its medical products.
The Mexborough-based company, which makes heated mattresses from an innovative carbon polymer that warms up when a low voltage is applied, says turnover is up by 25 per cent from £1.3 million to £1.7 million, while operating losses fell from £417,000 to £131,000.
Chairman Mark Abrahams says Inditherm made good progress in its core medical business, against a “backdrop of significant uncertainty” in the NHS.
Prospects have been boosted new guidelines on medical technology, issued by the National Institute for Health and Clinical Excellence (NICE), which recommend Inditherm’s mattress is used to prevent inadvertent hypothermia during surgery.
Inditherm’s mattress not only keeps patients warm, it has also been shown to cost £9,800 less to use for each operating theatre over a year, when compared to alternatives such as disposable blankets and forced air warming.
Mr Abrahams says the company, which now has partners in more than 50 countries, expects medical sales to continue growing and is also involved in a small number of potential projects which involve the firm’s technology being incorporated in other companies’ products.
“The Company has traded profitably in seven of the last twelve months to the end of February 2012, which includes a modestly profitable start to the current year. This gives us reason to be optimistic of entering a more profitable period,” says Mr Abrahams.
Inditherm’s innovative carbon polymer has been used for everything from below surface heating of sports pitches to curing concrete. Mattresses made from the polymer are used in hospital recovery rooms, accident and emergency departments, delivery suites and premature baby and intensive care units, as well as operating theatres.